journal
MENU ▼
Read by QxMD icon Read
search

Advances in Cancer Research

journal
https://www.readbyqxmd.com/read/28052824/preface
#1
EDITORIAL
Marvella E Ford, Dennis K Watson
No abstract text is available yet for this article.
2017: Advances in Cancer Research
https://www.readbyqxmd.com/read/28052823/social-networks-across-common-cancer-types-the-evidence-gaps-and-areas-of-potential-impact
#2
L J Rice, C H Halbert
Although the association between social context and health has been demonstrated previously, much less is known about network interactions by gender, race/ethnicity, and sociodemographic characteristics. Given the variability in cancer outcomes among groups, research on these relationships may have important implications for addressing cancer health disparities. We examined the literature on social networks and cancer across the cancer continuum among adults. Relevant studies (N=16) were identified using two common databases: PubMed and Google Scholar...
2017: Advances in Cancer Research
https://www.readbyqxmd.com/read/28052822/applying-a-conceptual-framework-to-maximize-the-participation-of-diverse-populations-in-cancer-clinical-trials
#3
A Napoles, E Cook, T Ginossar, K D Knight, M E Ford
The underrepresentation of ethnically diverse populations in cancer clinical trials results in the inequitable distribution of the risks and benefits of this research. Using a case study approach, we apply a conceptual framework of factors associated with the participation of diverse population groups in cancer clinical trials developed by Dr. Jean Ford and colleagues to increase understanding of the specific strategies, and barriers and promoters addressed by these strategies, that resulted in marked success in accrual of racially and ethnically diverse populations in cancer clinical research...
2017: Advances in Cancer Research
https://www.readbyqxmd.com/read/28052821/micrornas-and-their-impact-on-breast-cancer-the-tumor-microenvironment-and-disparities
#4
A Evans-Knowell, A C LaRue, V J Findlay
Breast cancer is a worldwide health issue as it represents the leading cause of cancer in women and the second-leading cause of cancer-related mortality in women, with an increasing incidence. Nothing speaks more clearly to the shocking breast cancer health disparities than the fact that African American (AA) women are as likely to get breast cancer as Caucasian American (CA) women, yet have a higher breast cancer death rate. It is becoming increasingly apparent that racial disparity in cancer exists due to molecular differences in tumor biology as well as, or in addition to, socioeconomic and standard of care issues (Albain, Unger, Crowley, Coltman, & Hershman, 2009)...
2017: Advances in Cancer Research
https://www.readbyqxmd.com/read/28052820/disparities-in-obesity-physical-activity-rates-and-breast-cancer-survival
#5
M E Ford, G Magwood, E T Brown, K Cannady, M Gregoski, K D Knight, L L Peterson, R Kramer, A Evans-Knowell, D P Turner
The significantly higher breast cancer (BCa) mortality rates of African-American (AA) women compared to non-Hispanic (NHW) white women constitute a major US health disparity. Investigations have primarily focused on biological differences in tumors to explain more aggressive forms of BCa in AA women. The biology of tumors cannot be modified, yet lifestyle changes can mitigate their progression and recurrence. AA communities have higher percentages of obesity than NHWs and exhibit inefficient access to care, low socioeconomic status, and reduced education levels...
2017: Advances in Cancer Research
https://www.readbyqxmd.com/read/28052819/disparities-in-cervical-cancer-incidence-and-mortality-can-epigenetics-contribute-to-eliminating-disparities
#6
R L Maguire, A C Vidal, S K Murphy, C Hoyo
Screening for uterine cervical intraepithelial neoplasia (CIN) followed by aggressive treatment has reduced invasive cervical cancer (ICC) incidence and mortality. However, ICC cases and carcinoma in situ (CIS) continue to be diagnosed annually in the United States, with minorities bearing the brunt of this burden. Because ICC peak incidence and mortality are 10-15 years earlier than other solid cancers, the number of potential years of life lost to this cancer is substantial. Screening for early signs of CIN is still the mainstay of many cervical cancer control programs...
2017: Advances in Cancer Research
https://www.readbyqxmd.com/read/28052818/the-role-of-advanced-glycation-end-products-in-cancer-disparity
#7
D P Turner
While the socioeconomic and environmental factors associated with cancer disparity have been well documented, the contribution of biological factors is an emerging field of research. Established disparity factors such as low income, poor diet, drinking alcohol, smoking, and a sedentary lifestyle may have molecular effects on the inherent biological makeup of the tumor itself, possibly altering cell signaling events and gene expression profiles to profoundly alter tumor development and progression. Our understanding of the molecular and biological consequences of poor lifestyle is lacking, but such information may significantly change how we approach goals to reduce cancer incidence and mortality rates within minority populations...
2017: Advances in Cancer Research
https://www.readbyqxmd.com/read/27613136/preface
#8
EDITORIAL
Danny R Welch, Paul B Fisher
No abstract text is available yet for this article.
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27613135/cytokine-regulation-of-metastasis-and-tumorigenicity
#9
M Yao, G Brummer, D Acevedo, N Cheng
The human body combats infection and promotes wound healing through the remarkable process of inflammation. Inflammation is characterized by the recruitment of stromal cell activity including recruitment of immune cells and induction of angiogenesis. These cellular processes are regulated by a class of soluble molecules called cytokines. Based on function, cell target, and structure, cytokines are subdivided into several classes including: interleukins, chemokines, and lymphokines. While cytokines regulate normal physiological processes, chronic deregulation of cytokine expression and activity contributes to cancer in many ways...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27613134/plasticity-of-cancer-cell-invasion-mechanisms-and-implications-for-therapy
#10
V Te Boekhorst, P Friedl
Cancer cell migration is a plastic and adaptive process integrating cytoskeletal dynamics, cell-extracellular matrix and cell-cell adhesion, as well as tissue remodeling. In response to molecular and physical microenvironmental cues during metastatic dissemination, cancer cells exploit a versatile repertoire of invasion and dissemination strategies, including collective and single-cell migration programs. This diversity generates molecular and physical heterogeneity of migration mechanisms and metastatic routes, and provides a basis for adaptation in response to microenvironmental and therapeutic challenge...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27613133/microrna-and-metastasis
#11
L Ma
Noncoding RNAs are important regulatory molecules of cellular processes. MicroRNAs (miRNAs) are small noncoding RNAs that bind to complementary sequences in the 3' untranslated region of target mRNAs, leading to degradation of the target mRNAs and/or inhibition of their translation. Some miRNAs are essential for normal animal development; however, many other miRNAs are dispensable for development but play a critical role in pathological conditions, including tumorigenesis and metastasis. miRNA genes often reside at fragile chromosome sites and are deregulated in cancer...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27613132/immune-regulation-of-the-metastatic-process-implications-for-therapy
#12
A de Mingo Pulido, B Ruffell
Metastatic disease is the major cause of fatalities in cancer patients, but few therapies are designed to target the metastatic process. Cancer cells must perform a number of steps to successfully establish metastatic foci, including local invasion, intravasation, survival, extravasation, and growth in ectopic tissue. Due to the nonrandom distribution of metastasis, it has long been recognized that the tissue microenvironment must be an important determinant of colonization. More recently it has been established in animal models that immune cells regulate the metastatic process, including a dominant role for monocytes and macrophages, and emerging roles for neutrophils and various lymphocyte populations...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27613131/breast-cancer-metastasis-suppressor-1-brms1-robust-biological-and-pathological-data-but-still-enigmatic-mechanism-of-action
#13
D R Welch, C A Manton, D R Hurst
Metastasis requires coordinated expression of multiple genetic cassettes, often via epigenetic regulation of gene transcription. BRMS1 blocks metastasis, but not orthotopic tumor growth in multiple tumor types, presumably via SIN3 chromatin remodeling complexes. Although there is an abundance of strong data supporting BRMS1 as a metastasis suppressor, the mechanistic data directly connecting molecular pathways with inhibition of particular steps in metastasis are not well defined. In this review, the data for BRMS1-mediated metastasis suppression in multiple tumor types are discussed along with the steps in metastasis that are inhibited...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27613130/defining-the-influence-of-germline-variation-on-metastasis-using-systems-genetics-approaches
#14
M Lee, N P S Crawford
Cancer is estimated to be responsible for 8 million deaths worldwide and over half a million deaths every year in the United States. The majority of cancer-related deaths in solid tumors is directly associated with the effects of metastasis. While the influence of germline factors on cancer risk and development has long been recognized, the contribution of hereditary variation to tumor progression and metastasis has only gained acceptance more recently. A variety of approaches have been used to define how hereditary variation influences tumor progression and metastasis...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27613129/the-relationship-between-dormant-cancer-cells-and-their-microenvironment
#15
N Linde, G Fluegen, J A Aguirre-Ghiso
The majority of cancer deaths are due to metastases that can occur years or decades after primary tumor diagnosis and treatment. Disseminated tumor cells (DTCs) surviving in a dormant state in target organs appear to explain the timing of this phenomenon. Knowledge on this process is important as it might provide a window of opportunity to prevent recurrences by eradicating dormant DTCs and/or by maintaining DTCs in a dormant state. Importantly, this research might offer markers of dormancy for early monitoring of metastatic relapse...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27613128/detecting-tumor-metastases-the-road-to-therapy-starts-here
#16
M E Menezes, S K Das, I Minn, L Emdad, X-Y Wang, D Sarkar, M G Pomper, P B Fisher
Metastasis is the complex process by which primary tumor cells migrate and establish secondary tumors in an adjacent or distant location in the body. Early detection of metastatic disease and effective therapeutic options for targeting these detected metastases remain impediments to effectively treating patients with advanced cancers. If metastatic lesions are identified early, patients might maximally benefit from effective early therapeutic interventions. Further, monitoring patients whose primary tumors are effectively treated for potential metastatic disease onset is also highly valuable...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27451127/evolving-strategies-for-therapeutically-targeting-cancer-stem-cells
#17
S Talukdar, L Emdad, S K Das, D Sarkar, P B Fisher
Cancer is a multifactor and multistep process that is affected intrinsically by the genetic and epigenetic makeup of tumor cells and extrinsically by the host microenvironment and immune system. A key component of cancer involves a unique subpopulation of highly malignant cancerous cells referred to as cancer stem cells (CSCs). CSCs are positioned at the apex of the tumor hierarchy with an ability to both self-renew and also generate non-CSC/differentiated progeny, which contribute to the majority of the tumor mass...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27451126/role-of-the-rb-interacting-proteins-in-stem-cell-biology
#18
M Mushtaq, H Viñas Gaza, E V Kashuba
Human retinoblastoma gene RB1 is the first tumor suppressor gene (TSG) isolated by positional cloning in 1986. RB is extensively studied for its ability to regulate cell cycle by binding to E2F1 and inhibiting the transcriptional activity of the latter. In human embryonic stem cells (ESCs), only a minute trace of RB is found in complex with E2F1. Increased activity of RB triggers differentiation, cell cycle arrest, and cell death. On the other hand, inactivation of the entire RB family (RB1, RBL1, and RBL2) in human ESC induces G2/M arrest and cell death...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27451125/aeg-1-mtdh-lyric-a-promiscuous-protein-partner-critical-in-cancer-obesity-and-cns-diseases
#19
L Emdad, S K Das, B Hu, T Kegelman, D-C Kang, S-G Lee, D Sarkar, P B Fisher
Since its original discovery in 2002, AEG-1/MTDH/LYRIC has emerged as a primary regulator of several diseases including cancer, inflammatory diseases, and neurodegenerative diseases. AEG-1/MTDH/LYRIC has emerged as a key contributory molecule in almost every aspect of cancer progression, including uncontrolled cell growth, evasion of apoptosis, increased cell migration and invasion, angiogenesis, chemoresistance, and metastasis. Additionally, recent studies highlight a seminal role of AEG-1/MTDH/LYRIC in neurodegenerative diseases and obesity...
2016: Advances in Cancer Research
https://www.readbyqxmd.com/read/27451124/h3k27-methylation-a-focal-point-of-epigenetic-deregulation-in-cancer
#20
J N Nichol, D Dupéré-Richer, T Ezponda, J D Licht, W H Miller
Epigenetics, the modification of chromatin without changing the DNA sequence itself, determines whether a gene is expressed, and how much of a gene is expressed. Methylation of lysine 27 on histone 3 (H3K27me), a modification usually associated with gene repression, has established roles in regulating the expression of genes involved in lineage commitment and differentiation. Not surprisingly, alterations in the homeostasis of this critical mark have emerged as a recurrent theme in the pathogenesis of many cancers...
2016: Advances in Cancer Research
journal
journal
23266
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"